Cargando…
Low tristetraprolin expression promotes cell proliferation and predicts poor patients outcome in pancreatic cancer
Tristetraprolin (also known as TTP, TIS11, ZFP36, and Nup475) is a well-characterized tumor suppressor that is down-regulated in several tumor types. In the current study, we found that TTP expression was markedly reduced in pancreatic cancer samples as compared to matched normal tissues. Low TTP le...
Autores principales: | Wei, Zi-Ran, Liang, Chao, Feng, Dan, Cheng, Ya-Jun, Wang, Wei-Min, Yang, De-Jun, Wang, Yue-Xiang, Cai, Qing-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951246/ https://www.ncbi.nlm.nih.gov/pubmed/26894969 http://dx.doi.org/10.18632/oncotarget.7397 |
Ejemplares similares
-
MCOLN1 Promotes Proliferation and Predicts Poor Survival of Patients with Pancreatic Ductal Adenocarcinoma
por: Hu, Zhan-Dong, et al.
Publicado: (2019) -
Roles of Tristetraprolin in Tumorigenesis
por: Park, Jeong-Min, et al.
Publicado: (2018) -
PIM2 interacts with tristetraprolin and promotes breast cancer tumorigenesis
por: Ren, Chune, et al.
Publicado: (2018) -
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function
por: Berglund, Anders E., et al.
Publicado: (2016) -
Role of Tristetraprolin in the Resolution of Inflammation
por: Rappl, Peter, et al.
Publicado: (2021)